Patents for A61P 17 - Drugs for dermatological disorders (106,455)
03/2009
03/05/2009US20090060898 Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
03/05/2009US20090060865 Mammalian receptor proteins; related reagents and methods
03/05/2009US20090060854 Dermatological Compound
03/05/2009US20090060853 Aminophenylbenzothiazole compounds
03/05/2009US20090060852 Compounds, Formulations and Methods for Reducing Skin Wrinkles, Creasing and Sagging
03/05/2009US20090060851 Use of idebenone for the preparation of a topically-applied depigmentation composition and corresponding composition
03/05/2009US20090060850 Ericacea extracts for combating skin aging
03/05/2009DE102008038697A1 Agent, useful for the treatment of neurodermatitis and/or psoriasis, comprises a component of toothbrush tree, preferably Salvadora persica
03/05/2009DE102007041735A1 Use of a multi-functional active substance mixture comprising a peptide fraction and an amino acid fraction, for producing a formulation for regulating the outer skin conditions of mammals including humans
03/05/2009DE102007041491A1 Kosmetische Pflegecreme Cosmetic cream
03/05/2009DE102007041475A1 Wirkstoffkombination aus Glycyrrhetinsäure und Erythrulose und kosmetische oder dermatologische Zubereitungen, diese Wirkstoffkombination enthaltend Active ingredient combination of glycyrrhetinic acid and Erythrulose and cosmetic or dermatological preparations, this drug combination containing
03/05/2009DE102007041473A1 Use of glycyrrhetinic acid and/or glycyrrhizin for manufacturing cosmetic or dermatological preparations to strengthen the natural skin tanning, treat skin and hair and reduce wrinkles
03/05/2009DE102007041472A1 Wirkstoffkombinationen aus Glycyrrhetinsäure und Dihydroxyaceton und kosmetische oder dermatologische Zubereitungen, diese Wirkstoffkombination enthaltend Active compound combinations of glycyrrhetinic acid and dihydroxyacetone and cosmetic or dermatological preparations, this drug combination containing
03/05/2009CA2709546A1 Surgical hydrogel
03/05/2009CA2697954A1 Sprayable composition comprising extract of red vine leaves
03/05/2009CA2697862A1 Supramacromolecular polymer complexes providing controlled nitric oxide release for healing wounds
03/05/2009CA2697670A1 Method for production of carotenoid
03/04/2009EP2030626A1 Process for the preparation of plant extracts for treating skin disorders and enhancing healing of wounds
03/04/2009EP2030616A1 Short-chain fatty acid derivatives for treating pruritus
03/04/2009EP2030612A1 Pharmaceutical composition for treating burns (variants) and a method for the production thereof (variants)
03/04/2009EP2029617A2 N-oxides of kappa opioid receptor peptides
03/04/2009EP2029600A1 Substituted pteridines substituted with a four-membered heterocycle
03/04/2009EP2029145A2 Pyrrolopyrimidine compounds and their uses
03/04/2009EP2029138A1 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
03/04/2009EP2029133A1 Compositions comprising at least one naphthoic acid derivative and at least one film-forming agent, methods for preparing same, and uses thereof
03/04/2009EP2029123A2 Use of a compound with rankl activity
03/04/2009EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase
03/04/2009EP1472209B1 Lipoxin a4 analogs
03/04/2009EP1455785B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
03/04/2009EP1453507B1 Solubilized topoisomerase poison agents
03/04/2009EP1452527B1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation
03/04/2009EP1427720B1 3-substituted-4-pyrimidone derivatives
03/04/2009EP1408931B1 Isotonic lipid emulsions
03/04/2009EP1255845B1 Modified cytokines for use in cancer therapy
03/04/2009EP1230243B1 Poycyloalkylpurines as adenosine receptor antagonists
03/04/2009EP1085804B1 Method and composition for the treatment of epidermal irritations and infections
03/04/2009CN101379089A Anti-ILT7 antibody
03/04/2009CN101378747A Whitening dermatological preparations
03/04/2009CN101378724A Skin-whitening cosmetic
03/04/2009CN101376005A Method for configuring cosmetic product for nourishing face
03/04/2009CN101375981A Chinese medicine preparation for treating tetanus, mouth ulcer, mastitis and trauma ulcer
03/04/2009CN101375966A Medicinal liquor for treating recurrent psoriasis in progressive stage
03/04/2009CN101375965A Chinese medicine honeyed bolus for treating recurrent psoriasis in progressive stage
03/04/2009CN101375960A Chinese medicinal composition for treating eczema and cutitis of children
03/04/2009CN101375953A Chinese medicine for treating psoriasis
03/04/2009CN101375933A Process for the preparation of plant extracts for treating skin disorders and enhancing healing of wounds
03/04/2009CN101375924A Externally appiled Chinese medicinal composition for treating chronic psoriasis in resting stage
03/04/2009CN101375861A Chinese medicine medical ointment for treating recurrent psoriasis in progressive stage
03/04/2009CN101375837A Medicament composition for treating dermatopathy as well as preparation method and use thereof
03/04/2009CN100465279C A preparation and an application of epiderm or hair follicle stem cells from sources of human early embryo
03/04/2009CN100465186C A composition and a method for inhibiting platelet aggregation
03/04/2009CN100464779C Hair-culturing alopecia-preventing liquid or hair-culturing nourishing liquid and a preparation method thereof
03/04/2009CN100464758C An application of Bijian grass in preparing medicines for treating diseases of tinea of hands, and tinea pedis
03/04/2009CN100464741C An aqueous-alcoholic depigmenting gel with phenolic derivatives and the vitamer A
03/03/2009US7498435 One amine is substituted with a fused heterocyclic ring and the other with a fused heterocyclic ring or phenyl ring, e.g., N2,N4-Bis(3,4-ethylenedioxyphenyl)-5-cyano-2,4-pyrimidinediamine; inhibit IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators such as histamine
03/03/2009US7498420 Human monoclonal antibody for use in the diagnosis prevention and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics
03/03/2009US7498417 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy
03/03/2009US7498416 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
03/03/2009US7498406 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants
03/03/2009US7498358 Human ADAM-10 inhibitors
03/03/2009US7498335 Method of producing an antiangiogenic or vascular permeability reducing effect
03/03/2009US7498334 Pyrrolopyrimidines as phosphodiesterase VII inhibitors
03/03/2009US7498323 Spiro-piperidine compounds and medicinal use thereof
03/03/2009US7498038 Chitin microparticles and their medical uses
03/03/2009US7498034 Imaging, diagnosis and treatment of disease
03/03/2009US7498032 Methods for treating immune disorders or cancer with anti-CD40 antibodies
03/03/2009CA2420222C Orally administered peptides to ameliorate atherosclerosis
03/03/2009CA2410880C 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds
03/03/2009CA2258165C N-[4-(heteroarylmethyl)phenyl]-heteroarylamines
02/2009
02/27/2009CA2599082A1 Supramacromolecular polymer complexes providing controlled nitric oxide release for healing wounds
02/26/2009WO2009026158A2 Inflammation-regulating compositions and methods
02/26/2009WO2009025797A1 Compositions and methods for treating symptoms of aging
02/26/2009WO2009025328A1 Ascorbic acid derivative or salt thereof, method for producing the same, and cosmetic preparation
02/26/2009WO2009025239A1 Novel preparation for external use
02/26/2009WO2009024707A2 Use of radamea montana extract for preparing a cosmetic composition
02/26/2009WO2009024680A1 Use of oleocanthal for treatment of cutaneous inflammation
02/26/2009WO2009024677A2 Use of hyaluronic acid for preparing compositions for improving the function of skin, eye and mucous membrane protection
02/26/2009WO2009024361A1 Hair treatment compositions with alcohol(s) and melatonin/agomelatine
02/26/2009WO2009024360A1 Hair treatment compositions with surfactant(s) and melatonin/agomelatin
02/26/2009WO2009024359A1 Hair treatment agent with conditioner(s) and melatonin/agomelatin
02/26/2009WO2009023918A1 Method of producing plant extract formulations
02/26/2009WO2008152330A3 Use of 4-phenyl-imidazole-2-thiones as tyrosinase inhibitors for preparing pharmaceutical or cosmetic compositions for treating or preventing pigment disorders
02/26/2009WO2008135361A3 Antifungal foam containing ciclopiroxolamine and zinc pyrithione, and medical and cosmetic applications thereof
02/26/2009WO2008130607A3 Wound healing compositions containing keratin biomaterials
02/26/2009WO2008030579A3 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder
02/26/2009US20090054522 Hair Care Product
02/26/2009US20090054521 Zwitterionic compounds and use thereof
02/26/2009US20090054495 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis
02/26/2009US20090054486 Polymorphic form xvi of fexofenadine hydrochloride
02/26/2009US20090054451 Use of Piperidine Derivatives as Agonists of Chemokine Receptor Activity
02/26/2009US20090054424 Optically active pyridine derivative and a medicament containing the same
02/26/2009US20090054409 [4-(4-imidazo[1,2-a]pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-morpholin-4-yl-methanone, used for treating rheumatoid arthritis in mammals
02/26/2009US20090054389 Topical Composition Comprising an Antibacterial Substance
02/26/2009US20090054378 Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines
02/26/2009US20090054349 Peptides for Promoting Hair Growth and Improving Wrinkle and Cosmetic Compositions Comprising the same
02/26/2009US20090054346 Elastin production-enhancing agents
02/26/2009US20090054323 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT
02/26/2009US20090054302 Methods and Preparations For Curing Clinically Ill Patients
02/26/2009US20090054300 Using protein profiles aspredictive tools in prognosis and treatment of immune related disorders
02/26/2009US20090053805 Post-partum mammalian placenta, its use and placental stem cells therefrom